Former Novo Nordisk CSO Marcus Schindler on R&D leadership, pharma innovation, scientific discovery, AI, global talent, DEI, biotech, drug development strategy.

The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...

To cut a long story short, us NME readers sneered - a privilege of youth, I suppose. Then, after another thumb in the nose of ...

The 'wild child' granddaughter of billionaire Rupert Murdoch has continued to wow her followers with her extreme makeover.

The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...

Okava Pharmaceuticals, a biopharmaceutical company, has launched a pilot study of a GLP-1 drug for cats with obesity ...

For countless fat jab users, a swollen tummy, waves of nausea and embarrassing gas have become part and parcel of the ...

Weight loss drugs may still help to fight against Alzheimer’s disease, despite a study by the manufacturer of Ozempic showing ...

Britain sanctioned Russia’s GRU intelligence agency and summoned Moscow’s ambassador on Thursday after an inquiry concluded that President Vladimir Putin was responsible for a nerve ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

Britain and Norway will mount joint naval patrols to protect undersea cables from Russia, the U.K. said Thursday, as Prime ...

Brightstar Lottery PLC (NYSE:BRSL) ("Brightstar") announced the successful pricing of $750,000,000 5.750% Senior Secured ...